|
๐
|
EULAR revised recommendations for the management of fibromyalgia
19 auth.
G. Macfarlane,
C. Kronisch,
L. Dean,
F. Atzeni,
Winfried Hรคuser,
Elisa Flรผร,
E. Choy,
E. Kosek,
K. Amris,
J. Branco,
...
F. Dฤฐnรer,
P. Leino-Arjas,
K. Longley,
G. McCarthy,
S. Makri,
S. Perrot,
P. Sarzi-Puttini,
Ann Taylor,
G. Jones
|
10 |
2016 |
10
๐
|
|
๐
|
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update
26 auth.
R. Agca,
S. Heslinga,
S. Rollefstad,
M. Heslinga,
I. McInnes,
M. Peters,
T. Kvien,
M. Dougados,
H. Radner,
F. Atzeni,
J. Primdahl,
A. Sรถdergren,
S. W. Jonsson,
J. V. Rompay,
C. Zabalan,
...
T. Pedersen,
L. Jacobsson,
K. Vlam,
M. Gonzรกlez-Gay,
A. Semb,
G. Kitas,
Y. Smulders,
Z. Szekanecz,
N. Sattar,
D. Symmons,
M. Nurmohamed
|
10 |
2016 |
10
๐
|
|
๐ข
|
Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment
P. Sarzi-Puttini,
V. Giorgi,
D. Marotto,
F. Atzeni
|
8 |
2020 |
8
๐ข
|
|
๐
|
Osteoarthritis: an overview of the disease and its treatment strategies.
8 auth.
P. Sarzi-Puttini,
M. Cimmino,
R. Scarpa,
R. Caporali,
F. Parazzini,
A. Zaninelli,
...
F. Atzeni,
B. Canesi
|
8 |
2005 |
8
๐
|
|
๐ฌ
|
The Prevalence of Fibromyalgia in the General Population: A Comparison of the American College of Rheumatology 1990, 2010, and Modified 2010 Classification Criteria
G. Jones,
F. Atzeni,
Marcus John Beasley,
Elisa Flรผร,
P. Sarzi-Puttini,
G. Macfarlane
|
8 |
2015 |
8
๐ฌ
|
|
๐
|
From endothelial dysfunction to atherosclerosis.
18 auth.
S. Sitia,
L. Tomasoni,
F. Atzeni,
G. Ambrosio,
C. Cordiano,
A. Catapano,
S. Tramontana,
F. Perticone,
P. Naccarato,
P. Camici,
...
E. Picano,
L. Cortigiani,
M. Bevilacqua,
L. Milazzo,
D. Cusi,
C. Barlassina,
P. Sarzi-Puttini,
M. Turiel
|
8 |
2010 |
8
๐
|
|
๐
|
Long-term prognosis and causes of death in systemic lupus erythematosus.
9 auth.
A. Doria,
L. Iaccarino,
A. Ghirardello,
S. Zampieri,
S. Arienti,
P. Sarzi-Puttini,
...
F. Atzeni,
A. Piccoli,
S. Todesco
|
8 |
2006 |
8
๐
|
|
๐
|
A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis.
8 auth.
K. Bechman,
S. Subesinghe,
S. Norton,
F. Atzeni,
M. Galli,
A. Cope,
...
K. Winthrop,
J. Galloway
|
7 |
2019 |
7
๐
|
|
๐
|
EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome
28 auth.
G. Drosos,
D. Vedder,
E. Houben,
L. Boekel,
F. Atzeni,
S. Badreh,
D. Boumpas,
N. Brodin,
I. Bruce,
M. Gonzรกlez-Gay,
S. Jacobsen,
G. Kerekes,
F. Marchiori,
C. Mukhtyar,
M. Ramos-Casals,
...
N. Sattar,
K. Schreiber,
S. Sciascia,
E. Svenungsson,
Z. Szekanecz,
A. Tausche,
A. Tyndall,
V. van Halm,
A. Voskuyl,
G. Macfarlane,
M. Ward,
M. Nurmohamed,
M. Tektonidou
|
7 |
2022 |
7
๐
|
|
๐
|
Obesity and reduction of the response rate to antiโtumor necrosis factor ฮฑ in rheumatoid arthritis: An approach to a personalized medicine
16 auth.
E. Gremese,
A. Carletto,
M. Padovan,
F. Atzeni,
B. Raffeiner,
A. Giardina,
E. Favalli,
G. Erre,
R. Gorla,
M. Galeazzi,
...
R. Foti,
F. Cantini,
C. Salvarani,
I. Olivieri,
G. Lapadula,
G. Ferraccioli
|
7 |
2013 |
7
๐
|
|
๐ฌ
|
Cardiac involvement in systemic lupus erythematosus
A. Doria,
L. Iaccarino,
P. Sarzi-Puttini,
F. Atzeni,
M. Turriel,
M. Petri
|
7 |
2005 |
7
๐ฌ
|
|
๐
|
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients.
42 auth.
M. Pietrogrande,
S. De Vita,
A. Zignego,
P. Pioltelli,
D. Sansonno,
S. Sollima,
F. Atzeni,
F. Saccardo,
L. Quartuccio,
S. Bruno,
R. Bruno,
M. Campanini,
M. Candela,
L. Castelnovo,
A. Gabrielli,
...
G. Gaeta,
P. Marson,
M. Mascia,
C. Mazzaro,
F. Mazzotta,
P. Meroni,
C. Montecucco,
E. Ossi,
F. Piccinino,
D. Prati,
M. Puoti,
P. Riboldi,
A. Riva,
D. Roccatello,
E. Sagnelli,
P. Scaini,
S. Scarpato,
R. Sinico,
G. Taliani,
A. Tavoni,
E. Bonacci,
P. Renoldi,
D. Filippini,
P. Sarzi-Puttini,
C. Ferri,
G. Monti,
M. Galli
|
7 |
2011 |
7
๐
|
